What does perineural invasion mean in my Breast Cancer pathology report

Breast CancerMay 17, 2026Navis AI

For informational purposes only

This answer was generated by AI grounded in NCCN guidelines and published medical literature. It is not medical advice. Always consult your oncologist or care team before making treatment decisions.

Understanding Perineural Invasion in Your Breast Cancer Report

Perineural invasion (PNI) is a finding that describes whether cancer cells have grown into or around the nerves in your breast tissue. Let me break down what this means and why your pathologist included it in your report.

What It Means

Perineural invasion occurs when cancer cells infiltrate the space surrounding nerves (the sheath that wraps around nerve fibers). Think of it like cancer cells traveling along the "highways" that nerves provide through your tissue.

When your pathology report mentions PNI, it's describing:

  • Present (positive): Cancer cells were found invading nerve sheaths
  • Absent (negative): No cancer cells were found in or around nerves
  • Not assessed: The pathologist didn't specifically evaluate this feature

Why This Matters Clinically

According to NCCN Guidelines for Metastatic Breast Cancer, pathologists examine multiple features of your tumor to help oncologists understand the cancer's behavior and plan treatment. Perineural invasion is one of these important characteristics because:

  1. It may indicate aggressive tumor behavior - Cancer cells that invade nerves can potentially spread more easily through nerve pathways
  2. It helps guide treatment decisions - This finding, combined with other factors like hormone receptor status (ER/PR), HER2 status, and lymph node involvement, helps your oncologist determine whether you need chemotherapy or other systemic treatments
  3. It contributes to risk assessment - Along with grade, stage, and other biomarkers, PNI helps estimate recurrence risk

Important Context

Perineural invasion is just ONE piece of information in your complete pathology report. Your oncologist will consider:

  • Tumor grade (how abnormal the cells look)
  • Tumor size
  • Lymph node status
  • Hormone receptor status (ER/PR positive or negative)
  • HER2 status
  • Other biomarkers (like those found through genomic testing such as Oncotype DX)

According to the NCCN Guidelines, treatment planning starts with comprehensive testing of your tumor. As noted in their patient guidance, "Not all breast cancers are the same. Treatment planning starts with testing."

Questions to Ask Your Oncologist

Since perineural invasion is part of your pathology findings, consider asking your care team:

  1. "Was perineural invasion present in my tumor, and what does that mean for my specific case?"
  2. "How does this finding influence my treatment recommendations?"
  3. "Are there other features in my pathology report that are more significant for treatment planning?"
  4. "Will this affect my follow-up monitoring or survivorship plan?"
  5. "Should I have any additional testing (like genomic testing) to help guide treatment decisions?"

Moving Forward

Your pathologist included this finding because it's part of the complete picture of your cancer. However, your oncologist will determine how much weight to give this finding compared to other factors when making treatment recommendations specifically for you. The presence or absence of perineural invasion doesn't automatically change treatment—it's considered alongside everything else about your tumor.


This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions.

This is general information.

Upload your records for guidance specific to YOUR diagnosis — personalized to your biomarkers, stage, and treatment history.

Get guidance specific to your case

This answer covers general information. For guidance based on YOUR records, biomarkers, and treatment history: